Boditech Med Inc. has been developing products for in-vitro diagnostics and diagnostic reagents for the past 20 years. Our company value "Respect for Life" puts the emphasis on customer satisfaction. In particular, some 50,000 ichroma™ readers have been installed worldwide. Ichroma™ CRP (C-Reactive Protein) has secured its largest market share in China, showing a unique competitiveness.
Boditech Med is leading the way in exploring new markets through the automation of on-site diagnosed immunodiagnostic devices and the development of new high-sensitive diagnostic reagents. We have built up our reputation by successfully carrying out various national R&D projects, based on solid technology, experience, and human resources.